16
Views
2
CrossRef citations to date
0
Altmetric
Review

Dermatological disease in Latinos in the USA

&
Pages 87-100 | Published online: 10 Jan 2014

References

  • Aguirre-Molina M, Molina C. Latino populations: who are they? In: Latino Health in the US: A Growing Challenge. Molina C, Aguirre-Molina M (Eds). American Public Health Association, DC, USA 3–22 (1994).
  • Taylor SC. Skin of color: biology, structure, function, and implications for dermatologic disease. J. Am. Acad. Dermatol.46, S41–S62 (2002).
  • CDC. Access to Health-Care and Preventive Services Among Latinos and Non-Latinos – United States, 2001–2002. MMWR53, 937–941 (2004)
  • McLaurin JA. Health care for children of migrant farmworkers. In: Ambulatory Pediatrics (5th Edition). Green M, Haggerty R, Weitzman M (Eds). WB Saunders, PA, USA 524–529 (1999).
  • Eisenman DP, Gelberg L, Liu H et al. Mental health and health-related quality of life among adult Latino primary care patients living in the United States with previous exposure to political violence. JAMA290, 627–634 (2003).
  • Sanchez MR. Cutaneous diseases in Latinos. Dermatol. Clin.21(4), 689–697 (2003).
  • Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol. Clin.18(1), 91–98 (2000).
  • Mandry Pagan R, Sanchez JL. Mandibular melasma. Puerto Rico Health Sci. J.19, 231 (2000).
  • Sialy R, Hassan I, Kaur I et al. Melasma in men: a hormonal profile. J. Am. Acad. Dermatol.27, 64 (2000).
  • Halder RM, Nootheti PK. Ethnic skin disorders overview. J. Am. Acad. Dermatol.48(6S), 143–148 (2003).
  • Guevara IL, Pandya AG. Melasma treated with hydroquinone, tretinoin, and a fluorinated steroid. Int. J. Dermatol.40(3), 212–215 (2001).
  • Hardwick N, Van Gelder LW, Van der Merwe CA et al. Exogenous ochronosis: an epidemiological study. Br. J. Dermatol.120(2), 229–238 (1989).
  • Kramer K, Lopez A, Stefanato CM et al. Exogenous ochronosis. J. Am. Acad. Dermatol.42, 869–871 (2000).
  • Mahe A, Ly F, Aymard G et al. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Br. J. Dermatol.148(3), 493–500 (2003).
  • Sarkar R, Bhalla M, Kanwar AJ. A comparative study of 20 percent azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients. Dermatology205, 249 (2002).
  • Taylor SC, Torok H, Jones T et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis72, 67 (2003).
  • Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol. Surg.25(4), 282–284 (1999).
  • Serra-Baldrich E, Tribo MJ, Camarasa JG. Allergic contact dermatitis from kojic acid. Contact Dermatitis39(2), 86–87 (1998).
  • Pinnell SR. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J. Am. Acad. Dermatol.48(1), 1–19 (2003).
  • Hurley ME, Guevera IL, Gonzales RM et al. Efficacy of glycolic acid peels in the treatment of melasma. Arch. Dermatol.138, 1578–1582 (2002).
  • Nouri K, Bowes L, Charier T et al. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol. Surg.25, 494 (1999).
  • Battle EF, Hobbs LM. Laser therapy on darker ethnic skin. Dermatol. Clin.21, 713–723 (2003).
  • Jackson BA. Lasers in ethnic skin: A review. J. Am. Acad. Dermatol.48, S134–S138 (2003).
  • Victor FC, Gelber J, Rao B. Melasma: a review. J. Cutan. Med. Surg.8(2), 97–102 (2004).
  • Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol. Surg.31(12), 1645–1650 (2005).
  • Perez-Bernal A, Munoz-Perez MA, Camacho R. Management of facial hyperpigmentation. Am. J. Clin. Dermatol.1, 261 (2000).
  • Serrano G, Pujol C, Cuadra J. Riehl’s melanosis: pigmented contact dermatitis caused by fragrances. J. Am. Acad. Dermatol.21, 1057 (1989).
  • Magana-Garcia M, Carrasco E, Herrera-Goepfert R et al. Hyperpigmentation of the clavicular zone: a variant of friction melanosis. Int. J. Dermatol.28(2), 119 (1989).
  • Osswald SS, Proffer LH, Sartori CR. Erythema dyschromicum perstans: a case report and review. Cutis.68, 25 (2001).
  • Penagos H, Jimenez V, Fallas V et al. Chlorothalonil, a possible cause of erythema dyschromicum perstans (ashy dermatitis). Contact Dermatitis35, 214 (1996).
  • Baranda L, Torres-Alvarez B, Cortes-Franco R et al. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy. Arch. Dermatol.133, 325 (1997).
  • Piquero-Martin J, Perez-Alfonzo R, Abrusci V et al. Clinical trial with clofazimine for treating erythema dyschromicum perstans. Evaluation of cell-mediated immunity. Int. J. Dermatol.28, 198 (1989).
  • Bahadir S, Cobanoglu U, Cimsit G et al. Erythema dyschromicum perstans: response to dapsone therapy. Int. J. Dermatol.43(3), 220–222 (2004).
  • Jansen T, Gambichler T, von Kobyletzki L et al. Lichen planus actinicus treated with acitretin and topical corticosteroids. Eur. Acad. Dermatol. Venereol.16, 174 (2002).
  • Albers SE, Glass LF, Fenske NA. Lichen planus subtropicus: direct immunoflourescence findings and therapeutic response to hydroxychloroquine. Int. J. Dermatol.33, 645 (1994).
  • Jang KA, Choi JH, Sung KS et al. Idiopathic eruptive macular pigmentation: report of 10 cases. J. Am. Acad. Dermatol.44, 351 (2001).
  • Boer A, Misago N, Wolter M et al. Prurigo pigmentosa: a distinctive inflammatory disease of the skin. Am. J. Dermatopathol.25, 117 (2003).
  • Dereure O. Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am. J. Clin. Dermatol.2(4), 253–262 (2001).
  • Passeron T, Ostovari N, Zakaria W et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch. Dermatol.140(9), 1065–1069 (2004).
  • Hay RJ, Estrada Castanon R, Alarcon Hernandez H et al. Wastage of family income on skin disease in Mexico. Br. Med. J.309, 848 (1994).
  • Kaya TI, Yazici AC, Tursen U et al. Idiopathic guttate hypomelanosis: idiopathic or ultraviolet induced? Photodermatol. Photoimmunol. Photomed.21(5), 270–271 (2005).
  • Pagnoni A, Kligman AM, Sadiq I et al. Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin. Acta Derm. Venereol.79(4), 305–310 (1999).
  • Hexsel DM. Treatment of idiopathic guttate hypomelanosis by localized superficial dermabrasion. Dermatol. Surg.25(11), 917–918 (1999).
  • Kumarasinghe SP. 3–5 second cryotherapy is effective in idiopathic guttate hypomelanosis. J. Dermatol.31(5), 437–439 (2004).
  • Taylor SC, Cook-Bolden F, Rahman Z et al. Acne vulgaris in skin of color. J. Am. Acad. Dermatol.46, S98–S106 (2002).
  • Murad H, Shamban AT, Moy LS. Polka-dot syndrome: a more descriptive name for a common problem. Cosmetic Dermatol.2, 57 (1993).
  • Fitzpatrick SB, Fujii C, Shragg GP et al. Do health care needs of indigent Mexican–American, black, and white adolescents differ? J. Adol. Health Care11, 128 (1990).
  • Halder RM. The role of retinoids in the management of cutaneous conditions in blacks. J. Am. Acad. Dermatol.39, S98–S103 (1998).
  • Freyre EA, Rebaza RM, Sami DA et al. The prevalence of facial acne in Peruvian adolescents and its relation to their ethnicity. J. Adol. Health Care22, 480 (1998).
  • Thiboutot DM, Strauss JS. Diet and acne revisited. Arch. Dermatol.138, 1591 (2002).
  • Cordain L, Lindeberg S, Hurtado M et al. Acne vulgaris: a disease of Western civilization. Arch. Dermatol.138, 1584 (2002).
  • Jackson BA. Cosmetic considerations and nonlaser cosmetic procedures in ethnic skin. Dermatol. Clin.21, 703–712 (2003).
  • Cornelison RL. Cutaneous diseases in Native Americans. Dermatol. Clin.21, 699–702 (2003).
  • Lopez-Gonzalez G. Prurigo solar. Arch. Argent. Dermatol.11, 301–318 (1961).
  • Magana M, Mendez Y, Rodriguez A et al. The conjunctivitis of solar (actinic) prurigo. Pediatr. Dermatol.17, 432 (2000).
  • Hojyo-Tomoka T, Granados J, Varga-Alarcon G et al. Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo. J. Am. Acad. Dermatol.36, 935 (1997).
  • Lane PR, Murphy F, Hogan DJ et al. Histopathology of actinic prurigo. Am. J. Dermatopathol.15, 326 (1993).
  • Herrera-Geopfert R, Magana M. Follicular cheilitis: a distinctive histopathologic finding in actinic prurigo. Am. J. Dermatopathol.17, 357–361 (1995).
  • Perrett CM, Harwood CA, Khorshid M et al. Primary cutaneous B-cell lymphoma associated with actinic prurigo. Br. J. Dermatol.153, 186–189 (2005).
  • Lovell CR, Hawk JL, Calnan CD et al. Thalidomide in actinic prurigo. Br. J. Dermatol.108, 467 (1983).
  • Duran MM, Ordonez CP, Prieto JC et al. Treatment of actinic prurigo in Chimila Indians. Int. J. Dermatol.35, 413 (1996).
  • Lane PR, Moreland AA, Hogan DJ. Treatment of actinic prurigo with intermittent short-course topical 0.05 percent clobetasol 17-propionate. A preliminary report. Arch Dermatol.126, 1211 (1990).
  • Las DY, Youn JI, Park MH et al. Actinic prurigo: limited effect of PUVA. Br. J. Dermatol.136, 972 (1997).
  • Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br. J. Dermatol.132, 956 (1995).
  • McCoombes JA, Hirst LW, Green WR. Use of topical cyclosporin for conjunctival manifestations of actinic prurigo. Am. J. Ophthalm.130, 830 (2000).
  • Torres-Alvarez B, Castanedo-Cazares JP, Moncada B. Pentoxifylline in the treatment of actinic prurigo. Dermatology208, 198–201 (2004).
  • Wei ML. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment. Cell Res.19, 19–42 (2006).
  • Santiago Borrero PJ, Rodriguez-Perez Y, Renta JY et al. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico. J. Invest. Dermatol.125, 85–90 (2006).
  • Toro J, Turner M, Gahl WA. Dermatologic manifestations of Hermansky-Pudlak syndrome in patients with and without a 16-base pair duplication in the HPS1 gene. Arch. Dermatol.135, 774 (1999).
  • Fett DD. Botanical briefs: capsicum peppers. Cuti.72(1), 21–23 (2003).
  • Lee MR, Shumack S. Prurigo nodularis: a review. Australas. J. Dermatol.46, 211 (2005).
  • Burnett JW. Capsicum pepper dermatitits. Cutis534 (1989).
  • Jones LA, Tandberg D, Troutman WG. Household treatment for “chile burns” of the hands. Clin. Toxicol.25, 483 (1987).
  • Stoner JG. Miscellaneous dermatitis-inducing plants. Clin. Dermatol.4, 86–94 (1986).
  • Kizer WS, Prarie T, Morey AF. Balanitis xerotica obliterans: epidemiologic distribution in an equal access healthcare system. South Med. J.96, 9 (2003).
  • Kiss A, Kiraly L, Kutasy B et al. High incidence of balanitis xerotica obliterans in boys with phimosis: prospective 10-year study. Pediatr. Dermatol.22(4), 305–308 (2005).
  • Drut RM, Gomez MA, Drut R. Human papillomavirus is present in some cases of childhood penile lichen sclerosus: an in situ hybridization and SP-PCR study. Pediatr. Dermatol.15, 85 (1998).
  • Kumaran MS, Kanwar AJ. Squamous cell carcinoma in untreated lichen sclerosus of the penis: a rare complication. J. Dermatol.31(3), 239–241 (2004).
  • Nasca MR, Innocenzi D, Micali G. Penile cancer among patients with genital lichen sclerosus. J. Am. Acad. Dermatol.41, 911 (1999).
  • Mallon E, Hawkins D, Dinneen M. Circumcision and genital dermatoses. Arch. Dermatol.136, 350 (2000).
  • Vincent MV, Mackinnon E. The response of clinical balanitis xerotica obliterans to the application of topical steroid-based creams. J. Pediatr. Surg.40(4), 709–712 (2005).
  • Das S, Tunuguntla HS. Balanitis xerotica obliterans – a review. World J. Urol.18(6), 382–387 (2000).
  • Burke JP, Duggirala R, Hale DE et al. Genetic basis of acanthosis nigricans in Mexican Americans and its association with phenotypes related to Type 2 diabetes. Hum. Genet.106, 467 (2000).
  • Litonjua P, Pinero-Pilona A, Aviles-Santa L et al. Prevalence of acanthosis nigricans in newly-diagnosed Type 2 diabetes. Endocr. Pract.10(2), 101–106 (2004).
  • Caballero AE. Diabetes in the Latino or Latino population: genes, environment, culture, and more. Curr. Diab. Rep.5(3), 217–225 (2005).
  • Mukhtar Q, Cleverley G, Voorhees RE et al. Prevalence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents. J. Adolesc. Health28, 372–376 (2001).
  • Barbieri RL. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance. Am. J. Obstet. Gynecol.183(6), 1412–1418 (2000).
  • Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am. J. Clin. Dermatol.5(3), 199–203 (2004).
  • Blobstein SH. Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity. Cutis71(1), 33–34 (2003).
  • Rosenbach A, Ram R. Treatment of Acanthosis nigricans of the axillae using a long-pulsed (5-msec) alexandrite laser. Dermatol. Surg.30(8), 1158–1160 (2004).
  • Mishriki YY. Skin commotion from repetitive devotion. Prayer callus. Postgrad. Med.105, 153 (1999).
  • Kahana M, Cohen M, Ronnen M et al. Prayer nodules in Moslem men. Cutis38(4), 281–282 (1986).
  • Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Latino whites, Latinos, Asians, and blacks: an analysis of California cancer registry data, 1988–1993. Cancer Causes Control8, 246 (1997).
  • Hu S, Soza-Vento RM, Parker DF et al. Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in Miami-Dade County, Florida. Arch. Dermatol.142, 704 (2006).
  • Black WC, Goldhahn RT, Wiggins C. Melanoma within a southwestern Latino population. Arch. Dermatol.123, 1331 (1987).
  • Piptone M, Robinson JK, Camara C et al. Skin cancer awareness in suburban employees: a Latino perspective. J. Am. Acad. Dermatol.47, 118–123 (2002).
  • Hoegh HJ, Davis BD, Manthe AF. Sun avoidance practices among non-Latino white Californians. Health Edu. Behavior26, 360 (1999).
  • Friedman LC, Bruce S, Weinberg AD et al. Early detection of skin cancer: racial/ethnic differences in behaviors and attitudes. J. Cancer Edu.9, 105 (1994).
  • Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations – US Surveillance, Epidemiology, and End Results (SEER) program, 1992 to 2001. Arch. Dermatol.141, 477–481 (2005).
  • Hu S, Ma F, Collado-Mesa F et al. UV Radiation, latitude, and melanoma in US Latinos and Blacks. Arch Dermatol.140, 819–824 (2004).
  • Hoy WE. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider. Cancer77, 2489–2495 (1996).
  • Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985–1996. J. Am. Acad. Dermatol.45, 528 (2001).
  • Zemelman V, von Beck P, Alvarado O et al. Sexual dimorphism in skin eye and hair color and the presence of freckles in Chilean teenagers from two socioeconomic strata. Revista Medica de Chile130, 879 (2002).
  • Bigler C, Feldman J, Hall E et al. Pigmented basal cell carcinoma in Latinos. J. Am. Acad. Dermatol.34, 751 (1996).
  • Abarca JF, Casiccia CC. Skin cancer and ultraviolet-B radiation under the Antarctic ozone hole: southern Chile, 1987–2000. Photoderm. Photoimmunol. Photomed.18, 294 (2002).
  • Calderon-Garciduenas L, Delgado R, Calderon-Garciduenas A et al. Malignant neoplasms of the nasal cavity and paranasal sinuses: a series of 256 patients in Mexico City and Monterrey. Is air pollution the missing link? Otolaryngol. Head Neck Surg.122(4), 499–508 (2000).
  • Hurtig AK, San Sebastain M. Geographical differences in cancer incidence in the Amazon basin of Ecuador in relation to residence near oil fields. Int. J. Epidemiol.31, 1021 (2002).
  • Grinspan D, Bianini R. Chronic endemic regional hydroarsenicism. The manifestations of arsenic poisoning caused by drinking water. Medicina Cutanea Ibero-Latino-Americana13, 85 (1985).

Websites

  • US census data. www.census.gov/PressRelease/www/releases/archives/population/005164.html
  • Projected population of the USA. www.census.gov/ipc/www/usinterimproj/natprojtab01a.pdf
  • US cenus data. www.census.gov/population/www/socdemo/compraceho.html
  • National population estimates. www.census.gov/popest/national/asrh/NC-EST2004-srh.html
  • Causes of death in Latinos under 75 years of age. www.cdc.gov/nchs/data/hus/tables/2003/03hus030.pdf
  • US census data. www.census.gov/hhes/www.hlthin01.html
  • Ries LAG, Eisner MP, Kosary CL et al (Eds). SEER Cancer Statistics Review, 1975–2002, National Cancer Institute. Bethesda, MD http://seer.cancer.gov/csr/1975_2002/ based on November 2004 SEER data submission, posted to the SEER web site 2005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.